Vaccinex, Inc.
(NASDAQ : VCNX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
2.81%201.081.2%$533.54m
GILDGilead Sciences, Inc.
3.71%75.480.9%$476.83m
BIIBBiogen Inc.
1.76%334.191.3%$391.43m
CELGCelgene Corporation
2.36%83.761.2%$347.18m
ILMNIllumina, Inc.
2.52%321.303.5%$305.14m
REGNRegeneron Pharmaceuticals, Inc.
5.12%396.872.6%$240.18m
ALXNAlexion Pharmaceuticals, Inc.
5.42%128.072.0%$226.73m
VRTXVertex Pharmaceuticals Incorporated
3.89%184.561.9%$218.67m
SRPTSarepta Therapeutics, Inc.
4.50%137.2516.4%$178.82m
AAgilent Technologies, Inc.
2.35%67.171.5%$161.17m
BMRNBioMarin Pharmaceutical Inc.
5.41%104.834.4%$142.69m
LGNDLigand Pharmaceuticals Incorporated
5.48%211.0423.3%$121.68m
VKTXViking Therapeutics, Inc.
7.54%15.270.9%$120.47m
NKTRNektar Therapeutics
3.20%50.655.6%$112.54m
EXASExact Sciences Corporation
1.48%66.7425.3%$104.54m

Company Profile

Vaccinex, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. It focuses on developing antibody treatments relevant to cancer, inflammation, and auto-immune diseases, as well as products for the treatment of non-small cell lung cancer, osteosarcoma, melanoma and Huntington's diseases. The company was founded by Maurice Zauderer and Deepak Sahasrabudhe in 1997 and is headquartered in Rochester, NY.